These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23536448)

  • 1. Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence.
    Wong JC; Hasan MR; Rahman M; Yu AC; Chan SK; Schaeffer DF; Kennecke HF; Lim HJ; Owen D; Tai IT
    Int J Cancer; 2013 Oct; 133(7):1567-77. PubMed ID: 23536448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT.
    Yu ACY; Chern YJ; Zhang P; Pasiliao CC; Rahman M; Chang G; Ren J; Tai IT
    Cancer Biol Ther; 2021 Feb; 22(2):112-123. PubMed ID: 33446037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
    Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
    Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2/p53 protein expression in the development of colorectal adenocarcinoma.
    Abdel-Fattah G; Yoffe B; Krishnan B; Khaoustov V; Itani K
    J Gastrointest Surg; 2000; 4(1):109-14. PubMed ID: 10631371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
    Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
    World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puf-A promotes cancer progression by interacting with nucleophosmin in nucleolus.
    Cho HC; Huang Y; Hung JT; Hung TH; Cheng KC; Liu YH; Kuo MW; Wang SH; Yu AL; Yu J
    Oncogene; 2022 Feb; 41(8):1155-1165. PubMed ID: 34999733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells.
    Behrend L; Mohr A; Dick T; Zwacka RM
    Mol Cell Biol; 2005 Sep; 25(17):7758-69. PubMed ID: 16107721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas.
    Fukawa T; Ono M; Matsuo T; Uehara H; Miki T; Nakamura Y; Kanayama HO; Katagiri T
    Cancer Res; 2012 Nov; 72(22):5867-77. PubMed ID: 23019224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
    López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S
    Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation.
    Senapati P; Dey S; Sudarshan D; Das S; Kumar M; Kaypee S; Mohiyuddin A; Kodaganur GS; Kundu TK
    FEBS J; 2018 Sep; 285(18):3503-3524. PubMed ID: 30085406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of VEGF induces cellular senescence in colorectal cancer cells.
    Hasan MR; Ho SH; Owen DA; Tai IT
    Int J Cancer; 2011 Nov; 129(9):2115-23. PubMed ID: 21618508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma.
    Luo H; Zou J; Dong Z; Zeng Q; Wu D; Liu L
    Biochem J; 2012 Mar; 442(2):311-21. PubMed ID: 22132820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR signaling pathway is a target for the treatment of colorectal cancer.
    Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
    Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.